by 
Share On Social!
The US Food and Drug Administration (FDA) announced the approval of Dexcom G5, a mobile continuous glucose monitoring system (CGM).
This new system could be a great relief for the 12.8 percent of Latinos living with diabetes.
How will it work?
The user will carry a Bluetooth enable device attached to his/her body which will measure the levels of glucose under the skin,it will then send the information to the user’s smartphone.
According to Dexcom, Inc this is the first system of its kind approved by the FDA to measure glucose levels in the blood in adults and children as young as 2 years old.
“Dexcom is rapidly advancing technology for continuous glucose monitoring devices to improve diabetes management. Since January, the company has introduced the G4 PLATINUM CGM with Share, apps to enable the first CGM on the Apple Watch™ and now the Dexcom G5® Mobile CGM. These advances are making diabetes management more convenient and flexible than ever before,” stated Kevin Sayer, President and Chief Executive Officer of Dexcom. “We are excited for the promise this new technology holds for patients and caregivers.”
Dexcom G5 is expected to be launched in September.
Explore More:
Maternal & Child HealthBy The Numbers
20.7
percent
of Latino kids have obesity (compared to 11.7% of white kids)
